Proton Partners International Ltd., the company bringing high energy proton beam therapy to the UK, has announced a new construction partnership for its £35 million oncology centre, which will be known as the Rutherford Cancer Centre North West.
The agreement is between the subsidiary of Proton Partners International, Rutherford Estates North West and Interserve, the international support services and construction group. Work on site is scheduled to commence on January 8th, 2018.
The partnership is of strategic importance with the centre’s location in the growing £1 billion Knowledge Quarter (KQ) in Liverpool’s Paddington Village and will see the construction of a two-storey cancer treatment facility.
The Rutherford Cancer Centre North West will bring the most advanced treatments in cancer care to the region, including high energy proton beam therapy (a treatment not currently available in the UK), as well as the latest technology on the market to deliver radiotherapy, chemotherapy, imaging and diagnostics.
Conventional treatments will be available from 2018 and high-energy proton beam therapy will be available from 2019. The centre will treat up to 500 patients a year and treatment will be available to medically-insured private patients, self-paying patients and patients referred by the NHS.
Mike Moran, chief executive officer of Proton Partners International, said: “We are really pleased to announce that we have appointed Interserve, one of the world’s foremost support services and construction companies, as our partners. We are confident that their team will provide the very best quality and expertise in building our Rutherford Cancer Centre in Liverpool”.
Phil Shaw, divisional director at Interserve Construction, said: “The team’s knowledge, experience, innovation and expertise, together with a compelling offer at interview contributed to winning this contract. We are delighted to be embarking on a journey with Proton Partners International to jointly deliver a successful project”.
